Contract facts
NONENo full NAICS 325413 intel page yet. Browse NAICS intelligence
GENEPRINT(R) 24 SYSTEM, 400RXN KITS FOR PATIENT CARE TESTING. is a federal NONE award for National Institutes Of Health - Cc held by Promega Corp. Estimated value $295K ($228K obligated). Current period of performance ends Sep 30, 2026. Last award drew 1 bidder. Place of performance: FITCHBURG WI. Related solicitation 25-002231.
GENEPRINT(R) 24 SYSTEM, 400RXN KITS FOR PATIENT CARE TESTING.
Recompete timing
PublicCurrent PoP ends Sep 30, 2026 (40 days remaining). Agencies typically plan 12–18 months ahead — at 1.3 months out, that window is already open. The buying decision is likely already in motion.
Incumbent footprint
Public recordPromega Corp — $3.6M obligated across 61 awards (firm-wide, all agencies) · lead buyer Department of Justice (DOJ).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75N90025P00207?
75N90025P00207 (Geneprint(r) 24 SYSTEM 400rxn KITS for) is a National Institutes Of Health - Cc award with a potential value of $295K, currently held by Promega Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75N90025P00207?
National Institutes Of Health - Cc awarded 75N90025P00207 to Promega Corp (potential $295K).
Who is the incumbent on 75N90025P00207?
Promega Corp is the incumbent with $3.6M across 61 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.
When does Promega Corp’s 75N90025P00207 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
